335 related articles for article (PubMed ID: 20336058)
1. Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior.
Potter MC; Elmer GI; Bergeron R; Albuquerque EX; Guidetti P; Wu HQ; Schwarcz R
Neuropsychopharmacology; 2010 Jul; 35(8):1734-42. PubMed ID: 20336058
[TBL] [Abstract][Full Text] [Related]
2. Fluctuations in endogenous kynurenic acid control hippocampal glutamate and memory.
Pocivavsek A; Wu HQ; Potter MC; Elmer GI; Pellicciari R; Schwarcz R
Neuropsychopharmacology; 2011 Oct; 36(11):2357-67. PubMed ID: 21796108
[TBL] [Abstract][Full Text] [Related]
3. Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum.
Amori L; Wu HQ; Marinozzi M; Pellicciari R; Guidetti P; Schwarcz R
Neuroscience; 2009 Mar; 159(1):196-203. PubMed ID: 19138730
[TBL] [Abstract][Full Text] [Related]
4. Reduction of brain kynurenic acid improves cognitive function.
Kozak R; Campbell BM; Strick CA; Horner W; Hoffmann WE; Kiss T; Chapin DS; McGinnis D; Abbott AL; Roberts BM; Fonseca K; Guanowsky V; Young DA; Seymour PA; Dounay A; Hajos M; Williams GV; Castner SA
J Neurosci; 2014 Aug; 34(32):10592-602. PubMed ID: 25100593
[TBL] [Abstract][Full Text] [Related]
5. Targeted deletion of the kynurenine aminotransferase ii gene reveals a critical role of endogenous kynurenic acid in the regulation of synaptic transmission via alpha7 nicotinic receptors in the hippocampus.
Alkondon M; Pereira EF; Yu P; Arruda EZ; Almeida LE; Guidetti P; Fawcett WP; Sapko MT; Randall WR; Schwarcz R; Tagle DA; Albuquerque EX
J Neurosci; 2004 May; 24(19):4635-48. PubMed ID: 15140935
[TBL] [Abstract][Full Text] [Related]
6. A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats.
Koshy Cherian A; Gritton H; Johnson DE; Young D; Kozak R; Sarter M
Neuropharmacology; 2014 Jul; 82():41-8. PubMed ID: 24647121
[TBL] [Abstract][Full Text] [Related]
7. The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex.
Wu HQ; Pereira EF; Bruno JP; Pellicciari R; Albuquerque EX; Schwarcz R
J Mol Neurosci; 2010 Jan; 40(1-2):204-10. PubMed ID: 19690987
[TBL] [Abstract][Full Text] [Related]
8. Pre- and postnatal exposure to kynurenine causes cognitive deficits in adulthood.
Pocivavsek A; Wu HQ; Elmer GI; Bruno JP; Schwarcz R
Eur J Neurosci; 2012 May; 35(10):1605-12. PubMed ID: 22515201
[TBL] [Abstract][Full Text] [Related]
9. Age dependency of inhibition of alpha7 nicotinic receptors and tonically active N-methyl-D-aspartate receptors by endogenously produced kynurenic acid in the brain.
Alkondon M; Pereira EF; Eisenberg HM; Kajii Y; Schwarcz R; Albuquerque EX
J Pharmacol Exp Ther; 2011 Jun; 337(3):572-82. PubMed ID: 21270133
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex.
Bortz DM; Wu HQ; Schwarcz R; Bruno JP
Neuropharmacology; 2017 Jul; 121():69-78. PubMed ID: 28419874
[TBL] [Abstract][Full Text] [Related]
11. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
Wu HQ; Rassoulpour A; Schwarcz R
J Neural Transm (Vienna); 2007 Jan; 114(1):33-41. PubMed ID: 16932989
[TBL] [Abstract][Full Text] [Related]
12. Astrocytic localization of kynurenine aminotransferase II in the rat brain visualized by immunocytochemistry.
Guidetti P; Hoffman GE; Melendez-Ferro M; Albuquerque EX; Schwarcz R
Glia; 2007 Jan; 55(1):78-92. PubMed ID: 17024659
[TBL] [Abstract][Full Text] [Related]
13. Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry.
Konradsson-Geuken A; Wu HQ; Gash CR; Alexander KS; Campbell A; Sozeri Y; Pellicciari R; Schwarcz R; Bruno JP
Neuroscience; 2010 Sep; 169(4):1848-59. PubMed ID: 20600676
[TBL] [Abstract][Full Text] [Related]
14. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.
Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM
J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380
[TBL] [Abstract][Full Text] [Related]
15. Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex.
Beggiato S; Tanganelli S; Fuxe K; Antonelli T; Schwarcz R; Ferraro L
Neuropharmacology; 2014 Jul; 82():11-8. PubMed ID: 24607890
[TBL] [Abstract][Full Text] [Related]
16. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.
Hilmas C; Pereira EF; Alkondon M; Rassoulpour A; Schwarcz R; Albuquerque EX
J Neurosci; 2001 Oct; 21(19):7463-73. PubMed ID: 11567036
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Prenatal Kynurenine Metabolism Using Tissue Slices: Focus on the Neosynthesis of Kynurenic Acid in Mice.
Notarangelo FM; Beggiato S; Schwarcz R
Dev Neurosci; 2019; 41(1-2):102-111. PubMed ID: 31117076
[TBL] [Abstract][Full Text] [Related]
18. Astrocyte-derived kynurenic acid modulates basal and evoked cortical acetylcholine release.
Zmarowski A; Wu HQ; Brooks JM; Potter MC; Pellicciari R; Schwarcz R; Bruno JP
Eur J Neurosci; 2009 Feb; 29(3):529-38. PubMed ID: 19187269
[TBL] [Abstract][Full Text] [Related]
19. Increased kynurenic acid levels and decreased brain kynurenine aminotransferase I in patients with Down syndrome.
Baran H; Cairns N; Lubec B; Lubec G
Life Sci; 1996; 58(21):1891-9. PubMed ID: 8637415
[TBL] [Abstract][Full Text] [Related]
20. Kynurenic Acid Levels and Kynurenine Aminotransferase I, II and III Activities in Ganglia, Heart and Liver of Snail Helix Pomatia.
Kronsteiner C; Baran H; Kepplinger B
Cell Physiol Biochem; 2023 Aug; 57(4):279-297. PubMed ID: 37597169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
